An interventional study of 3D generated tooth replica in Tooth Loss, sponsored by Turku University Hospital. Recruiting at 1 site in Finland. Open to participants aged 9 Years to 23 Years. Per ClinicalTrials.gov, last updated 2025-05-14.
Sponsored by Turku University Hospital · Not applicable, Interventional, and Treatment
The study aims to clarify the usefulness of 3D-printed replicas in association with autotransplantation of teeth in children and young adults.
165 studies on the registry are indexed under Tooth Loss; 44 are open to participants now.
This study's planned enrollment of 120 is above the median of 30 across 120 interventional studies indexed under Tooth Loss.
Browse Tooth Loss studies →Turku University Hospital is the lead sponsor of 287 studies on the registry; 67 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Duration of surgery, degree of manipulation of the transplant
Device: 3D generated tooth replica
Normal eruption and root development of the transplant
Device: 3D generated tooth replica
3D generated tooth replicas are compared to conventional procedure
Number of patients with healthy transplanted teeth as assessed by clinical examination at one year.
The transplanted tooth is clinically healthy
Time frame: One year postoperatively
Number of patients with healthy transplanted teeth as assessed by radiological examination at one year.
The transplanted tooth is radiologically healthy
Time frame: One year postoperatively
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.